$1.985
0.015[0.76%]
At close: Apr 19
Can Fite Biofarma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Can Fite Biofarma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/30/2024 | AM | CANF | Q1 | $0.00 | -$0.40 | — | — | $196.00K | — | — | — | Get Alert |
03/28/2024 | AM | CANF | Q4 | -$1.11 | -$0.26 | -$0.01 | 96.15% | $197.00K | $100.00K | $155.00K | 55.00% | Get Alert |
11/30/2023 | AM | CANF | Q3 | -$0.01 | -$0.44 | -$0.43 | 2.27% | $613.00K | $100.00K | $196.00K | 96.00% | Get Alert |
08/31/2023 | AM | CANF | Q2 | -$0.80 | -$0.42 | -$0.40 | 4.76% | $204.00K | $100.00K | $196.00K | 9600.00% | Get Alert |
06/01/2023 | AM | CANF | Q1 | $0.00 | -$1.52 | -$0.65 | 57.24% | $205.00K | — | $196.00K | — | Get Alert |
03/30/2023 | AM | CANF | Q4 | -$0.10 | -$0.98 | -$1.11 | -13.27% | $204.00K | $330.00K | $197.00K | -40.30% | Get Alert |
11/25/2022 | AM | CANF | Q3 | -$0.10 | -$1.10 | -$0.10 | 90.91% | $251.00K | $200.00K | $204.00K | 2.00% | Get Alert |
08/25/2022 | AM | CANF | Q2 | -$0.10 | -$1.00 | -$0.80 | 20.00% | $250.00K | — | $204.00K | — | Get Alert |
05/26/2022 | AM | CANF | Q1 | $0.00 | -$1.40 | $0.00 | 100.00% | $148.00K | $200.00K | $205.00K | 2.50% | Get Alert |
03/24/2022 | AM | CANF | Q4 | -$0.10 | -$1.80 | -$0.10 | 94.44% | $150.00K | $250.00K | $204.00K | -18.40% | Get Alert |
11/26/2021 | AM | CANF | Q3 | $0.10 | -$0.90 | -$0.20 | 77.78% | $211.00K | $150.00K | $251.00K | 67.33% | Get Alert |
08/26/2021 | AM | CANF | Q2 | -$0.10 | -$1.00 | -$0.10 | 90.00% | $204.00K | $120.00K | $250.00K | 108.33% | Get Alert |
05/27/2021 | AM | CANF | Q1 | -$0.30 | -$1.60 | $0.00 | 100.00% | $198.00K | $200.00K | $148.00K | -26.00% | Get Alert |
03/25/2021 | AM | CANF | Q4 | $0.00 | — | -$0.10 | — | $192.00K | — | $150.00K | — | Get Alert |
11/30/2020 | AM | CANF | Q3 | -$0.30 | -$2.40 | $0.10 | 104.17% | $1.15M | $250.00K | $211.00K | -15.60% | Get Alert |
08/27/2020 | AM | CANF | Q2 | -$0.40 | -$3.30 | -$0.10 | 96.97% | $389.00K | $250.00K | $204.00K | -18.40% | Get Alert |
06/01/2020 | AM | CANF | Q1 | -$0.40 | -$6.60 | -$0.30 | 95.45% | $299.00K | $1.18M | $198.00K | -83.22% | Get Alert |
03/27/2020 | AM | CANF | Q4 | -$13.50 | — | $0.00 | — | $289.00K | — | $192.00K | — | Get Alert |
11/29/2019 | AM | CANF | Q3 | $0.00 | — | -$0.30 | — | $2.63M | — | $1.15M | — | Get Alert |
Can Fite Biofarma (CANF) is scheduled to report earnings on May 30, 2024. The last reported earnings were for reported on March 28, 2024 for Q4.
The Actual EPS was $-0.01, which beat the estimate of $-0.26.
The Actual Revenue was $155K, which beat the estimate of $100K.
Browse earnings estimates, EPS, and revenue on all stocks.